Compound Detail
CHEMBL422
TRIFLUOPERAZINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL422 |
| Name | TRIFLUOPERAZINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZEWQUBUPAILYHI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
41
Targets
93
Activities
4
Assay Types
4
PK Parameters
20
Publications
10
Known Names
2
Indications
Molecular Properties
407.5
MW (Da)
4.95
ALogP
4
HBA
0
HBD
9.7
PSA (Ų)
0.71
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1959 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Psychotic Disorders Anemia, Diamond-Blackfan
ATC Classification
N05AB06
trifluoperazine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
IC50 60 meas. best 7.8
Kd 15 meas. best 9.27
Ki 13 meas. best 8.66
EC50 5 meas. best 5.87
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL339 | Kd | 9.27 | 9.27 | 0.5 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Kd | 8.98 | 8.98 | 1.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.66 | 8.66 | 2.2 | 1 |
| Emopamil-binding protein-like CHEMBL2311238 | Ki | 8.41 | 8.41 | 3.9 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 8.28 | 8.28 | 5.2 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase CHEMBL4931 | Ki | 8.1 | 8.1 | 8.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 7.82 | 7.82 | 15.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.62 | 7.62 | 24.2 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 7.53 | 7.53 | 29.3 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 6.46 | 6.46 | 350.0 | 1 |
| ADMET CHEMBL612558 | Kd | 6.41 | 6.41 | 392.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 6.39 | 6.39 | 411.0 | 1 |
| C-8 sterol isomerase ERG2 CHEMBL3224 | Ki | 6.3 | 6.3 | 500.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 6.3 | 5.864 | 500.0 | 5 |
| NS3 CHEMBL1293269 | IC50 | 6.16 | 6.16 | 700.0 | 1 |
| Calmodulin-1 CHEMBL6093 | Kd | 6.0 | 6.0 | 1000.0 | 1 |
| N-formyl peptide receptor 2 CHEMBL4227 | IC50 | 5.97 | 5.9667 | 1060.0 | 3 |
| Unchecked CHEMBL612545 | IC50 | 5.94 | 4.7867 | 1140.0 | 6 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 5.91 | 5.91 | 1230.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.87 | 5.6133 | 1340.0 | 3 |
| Pleiotropic ABC efflux transporter of multiple drugs CHEMBL1697658 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.83 | 5.525 | 1480.0 | 2 |
| Nucleic Acid CHEMBL345 | Kd | 5.77 | 5.71 | 1700.0 | 3 |
| Plasmodium falciparum CHEMBL364 | EC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 5.57 | 5.094 | 2700.0 | 5 |
| Neutrophil CHEMBL613710 | IC50 | 5.57 | 5.1325 | 2700.0 | 4 |
| Mycolicibacterium smegmatis CHEMBL613088 | IC50 | 5.5 | 5.1067 | 3150.0 | 6 |
| Calmodulin CHEMBL6092 | Kd | 5.47 | 5.385 | 3400.0 | 2 |
| KG-1a CHEMBL4296453 | IC50 | 5.34 | 5.34 | 4580.0 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 5.29 | 5.29 | 5100.8 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.21 | 5.21 | 6226.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 5.2 | 5.1 | 6300.0 | 3 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Ki | 5.19 | 5.19 | 6500.0 | 1 |
| Beta-glucuronidase CHEMBL4814 | IC50 | 5.11 | 5.11 | 7800.0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48 CHEMBL3430885 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| Lysozyme C CHEMBL2297 | IC50 | 5.05 | 5.05 | 9000.0 | 1 |
| U-87 MG CHEMBL614247 | IC50 | 5.0 | 5.0 | 9900.0 | 1 |
| NSC CHEMBL4296523 | IC50 | 5.0 | 5.0 | 10100.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.99 | 4.99 | 10130.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.96 | 4.8633 | 10990.0 | 6 |
| MCF7 CHEMBL387 | IC50 | 4.95 | 4.95 | 11330.0 | 1 |
| U-87 MG CHEMBL614247 | EC50 | 4.87 | 4.87 | 13500.0 | 1 |
| Albumin CHEMBL4817 | Kd | 4.85 | 4.85 | 14000.0 | 1 |
| SK-BR-3 CHEMBL613834 | IC50 | 4.8 | 4.8 | 15890.0 | 1 |
| SUM-159-PT CHEMBL4483269 | IC50 | 4.77 | 4.77 | 17030.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.67 | 4.67 | 21580.0 | 1 |
| Trypanothione reductase CHEMBL5131 | Ki | 4.64 | 4.64 | 23000.0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 CHEMBL4693 | IC50 | 4.35 | 4.35 | 45000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 5.3 | nM | Homo sapiens |
| Fu | 0.0007 | - | Rattus norvegicus |
| Fu | 0.0018 | - | Sus scrofa |
| Fu | 0.0033 | - | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine